Genomic data optimizes hematopoietic stem-cell transplantation (HSCT) timing for myelodysplastic syndromes (MDS) and improves patient outcomes
1. A decision support system using the Molecular International Prognostic Scoring System (IPSS-M) can optimize the timing of HSCT for ...









![Genetic mutation identified that underlies familial myelodysplastic syndrome [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2015/01/Hypogranular_neutrophil_with_a_pseudo-Pelger-Huet_nucleus_in_MDS-350x250.jpg)
